<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wiki.tiffa.net/w/index.php?action=history&amp;feed=atom&amp;title=Translations%3AInsulin%2F47%2Fen</id>
	<title>Translations:Insulin/47/en - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wiki.tiffa.net/w/index.php?action=history&amp;feed=atom&amp;title=Translations%3AInsulin%2F47%2Fen"/>
	<link rel="alternate" type="text/html" href="https://wiki.tiffa.net/w/index.php?title=Translations:Insulin/47/en&amp;action=history"/>
	<updated>2026-07-08T17:52:28Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.0</generator>
	<entry>
		<id>https://wiki.tiffa.net/w/index.php?title=Translations:Insulin/47/en&amp;diff=129901&amp;oldid=prev</id>
		<title>FuzzyBot: Importing a new version from external source</title>
		<link rel="alternate" type="text/html" href="https://wiki.tiffa.net/w/index.php?title=Translations:Insulin/47/en&amp;diff=129901&amp;oldid=prev"/>
		<updated>2024-03-18T07:33:31Z</updated>

		<summary type="html">&lt;p&gt;Importing a new version from external source&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;The actions of insulin (indirect and direct) on cells include:&lt;br /&gt;
* Stimulates the uptake of glucose –  Insulin decreases blood glucose concentration by inducing [[cellular glucose intake|intake of glucose]] by the cells. This is possible because Insulin causes the insertion of the GLUT4 transporter in the cell membranes of muscle and fat tissues which allows glucose to enter the cell.&lt;br /&gt;
* Increased [[Fatty acid metabolism#Glycolytic endy products are used in the conversion of carbohydrates into fatty acids|fat synthesis]] – insulin forces fat cells to take in blood glucose, which is converted into [[triglyceride]]s; decrease of insulin causes the reverse.&lt;br /&gt;
* Increased [[esterification]] of fatty acids – forces adipose tissue to make neutral fats (i.e., [[triglycerides]]) from fatty acids; decrease of insulin causes the reverse.&lt;br /&gt;
* Decreased [[lipolysis]] in  – forces reduction in conversion of fat cell lipid stores into blood fatty acids and glycerol; decrease of insulin causes the reverse.&lt;br /&gt;
* Induced glycogen synthesis – When glucose levels are high, insulin induces the formation of glycogen by the activation of the hexokinase enzyme, which adds a phosphate group in glucose, thus resulting in a molecule that cannot exit the cell. At the same time, insulin inhibits the enzyme glucose-6-phosphatase, which removes the phosphate group. These two enzymes are key for the formation of glycogen. Also, insulin activates the enzymes phosphofructokinase and glycogen synthase which are responsible for glycogen synthesis.&lt;br /&gt;
* Decreased [[gluconeogenesis]] and [[glycogenolysis]] – decreases production of glucose from noncarbohydrate substrates, primarily in the liver (the vast majority of endogenous insulin arriving at the liver never leaves the liver); decrease of insulin causes glucose production by the liver from assorted substrates.&lt;br /&gt;
* Decreased [[proteolysis]] – decreasing the breakdown of protein&lt;br /&gt;
* Decreased [[Autophagy (cellular)|autophagy]] – decreased level of degradation of damaged organelles. Postprandial levels inhibit autophagy completely.&lt;br /&gt;
* Increased amino acid uptake – forces cells to absorb circulating amino acids; decrease of insulin inhibits absorption.&lt;br /&gt;
* Arterial muscle tone – forces arterial wall muscle to relax, increasing blood flow, especially in microarteries; decrease of insulin reduces flow by allowing these muscles to contract.&lt;br /&gt;
* Increase in the secretion of [[hydrochloric acid]] by parietal cells in the stomach.&lt;br /&gt;
* Increased potassium uptake – forces cells synthesizing [[glycogen]] (a very spongy, &amp;quot;wet&amp;quot; substance, that [[Glycogen#Structure|increases the content of intracellular water, and its accompanying K&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt; ions]]) to absorb potassium from the extracellular fluids; lack of insulin inhibits absorption. Insulin&amp;#039;s increase in cellular potassium uptake lowers potassium levels in blood plasma.  This possibly occurs via insulin-induced translocation of the [[Na+/K+-ATPase|Na&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt;/K&amp;lt;sup&amp;gt;+&amp;lt;/sup&amp;gt;-ATPase]] to the surface of skeletal muscle cells.&lt;br /&gt;
* Decreased renal sodium excretion.tocytes, insulin binding acutely leads to activation of protein phosphatase 2A (PP2A), which dephosphorylates the bifunctional enzyme [[Phosphofructokinase_2#PFKB1:_Liver,_muscle,_and_fetal | fructose bisphosphatase-2 (PFKB1)]], activating the phosphofructokinase-2 (PFK-2) active site. PFK-2 increases production of fructose 2,6-bisphosphate. [[Fructose 2,6-bisphosphate]] allosterically activates [[PFK-1]], which favors glycolysis over gluconeogenesis. Increased glycolysis increases the formation of [[malonyl-CoA]], a molecule that can be shunted into lipogenesis and that allosterically inhibits of [[Carnitine palmitoyltransferase I | carnitine palmitoyltransferase I (CPT1)]], a mitochondrial enzyme necessary for the translocation of fatty acids into the intermembrane space of the mitochondria for fatty acid metabolism.&lt;/div&gt;</summary>
		<author><name>FuzzyBot</name></author>
	</entry>
</feed>